General Information of the Compound
Compound ID |
CP0064571
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
1H-1,2,3-benzotriazol-1-amine
Show/Hide
|
||||||||||||||||||
Synonyms |
1-Abtz
1-Aminobenzotriazole, 98%
1-Benzotriazolamine
1-aminobenzotriazole
1-benzotriazolylamine
1614-12-6
1H-1,2,3-Benzotriazol-1-amine
1H-1,2,3-Benzotriazol-1-ylamine
1H-1,2,3-benzotriazol-1-amine
1H-Benzotriazol-1-amine
1H-benzo[d][1,2,3]triazol-1-amine
9EFF75BJ1O
ABT
AC1L1BBK
ACMC-1BVFA
AK-830/25033013
CHEMBL101168
Lopac-A-3940
MFCD00132902
NSC 114498
NSC656987
PubChem19954
Q-102063
UNII-9EFF75BJ1O
benzotriazol-1-amine
benzotriazol-1-ylamine
benzotriazolylamine
rarechem aq nn 0550
timtec-bb sbb004208
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C6H6N4
|
||||||||||||||||||
Molecular Weight |
134.142
|
||||||||||||||||||
Canonical SMILES |
Nn1nnc2ccccc12
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C6H6N4/c7-10-6-4-2-1-3-5(6)8-9-10/h1-4H,7H2
Show/Hide
|
||||||||||||||||||
InChIKey |
JCXKHYLLVKZPKE-UHFFFAOYSA-N
|
||||||||||||||||||
CAS |
1614-12-6
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT06367, Cytochrome P450 4Z1
Protein ID: PT06109, Geminin
Clinical Information about the Compound